In relief for Uttarakhand, the India Meteorological Department (IMD) on Sunday said that no adverse weather is expected in the next two days in Tapovan and Joshimath in the hill …
adverse
-
-
India Meteorological Department (IMD) Additional Director General Anand Sharma said Chamoli, Tapovan and Joshimath are likely to witness dry weather during the two days The MeT department Sunday said no …
-
A consent form for Covaxin, the coronavirus vaccine developed by Bharat Biotech is promising compensation to the receiver in case of “severe adverse event”. Although the vaccine has demonstrated ability …
-
The three cases occurred at different hospitals cum vaccination centres, the ministry added. “One has been discharged from Northern Railway Hospital Delhi within 24 hours. One has been discharged from …
- News
India’s Health Ministry reports 3 hospitalisations, 447 adverse events following COVID vaccination
India’s Health Ministry on Sunday reported 447 cases of “adverse event following immunisations” (AEFI) after the country began its vaccination drive on January 16, which is being called the largest …
- News
Coronavirus News LIVE Updates: Over 1.91 lakh people vaccinated on day 1, says Centre; Delhi, Maharashtra report adverse events – Health News , Firstpost
Coronavirus News LIVE Updates: More than one crore cases and 1.5 lakh fatalities later, India took its first steps out of the pandemic with shots of the Covishield and Covaxin …
- News
Bharat Biotech to pay compensation if Covaxin causes ‘severe adverse reaction’ in recipients – India News , Firstpost
The central licensing authority has granted permission for the sale or distribution of Covaxin for restricted use in emergency situations in public interest as an abundant caution, in clinical trial …
-
New Delhi: One “severe” and 51 “minor” cases of AEFI (adverse events following immunisation) were reported among health workers who were administered the coronavirus vaccine in Delhi on the first …
-
As India began its nationwide vaccination drive against Covid-19, Maharashtra recorded 14 cases of adverse events, none of them fatal, on Day 1 of the vaccination rollout in the state. …
- News
Covaxin produces ‘robust’ antibody response with no serious adverse events, Phase 1 trials show – Health News , Firstpost
The findings have appeared on medRxiv, a preprint server. A preprint is a version of a scientific manuscript posted on a public server prior to formal peer review COVAXIN vaccine …
- News
Bharat Biotech’s phase 1 trial findings show COVID-19 vaccine well tolerated; no serious adverse events
The interim findings of phase 1 clinical trial of COVID-19 vaccine Covaxin, indigenously developed by Bharat Biotech in collaboration with the ICMR, showed that it was was well tolerated in …
- News
COVID-19 vaccine: Bharat Biotech’s Covaxin Phase 1 trial shows it has no serious adverse events
COVID-19 vaccine Covaxin, indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), was well tolerated in all dose groups with no serious or adverse …
-
The possibility of an adverse event after being vaccinated for COVID-19 cannot be ruled out, the government said on Tuesday and asked states and Union Territories to be prepared for …
-
LIMA: Peru suspended trials for China’s Sinopharm COVID-19 vaccine due to a “serious adverse event” that occurred with one of the volunteers for the study, the Peruvian government said in …
-
Britain’s medicine regulator said anyone with a history of anaphylaxis to a medicine or food should not get the Pfizer-BioNTech COVID-19 vaccine, giving fuller guidance on an earlier allergy warning …
- News
Coronavirus LIVE Updates: UK Issues Anaphylaxis Warning on Pfizer Vaccine After Adverse Reactions; Canada Approves First Covid-19 Shot
Coronavirus LIVE Updates: Britain’s medicine regulator said anyone with a history of anaphylaxis to a medicine or food should not get the Pfizer-BioNTech COVID-19 vaccine, giving fuller guidance on an …
-
LONDON: Britain’s medicine regulator warned people with significant allergies not to get Pfizer-BioNTech’s COVID-19 vaccine after two people suffered adverse reactions, but was set to give more detailed guidance on …
- General
UK investigates two adverse reactions to Pfizer jab, says people with history of serious allergic reactions shouldn’t get inoculated – World News , Firstpost
Professor Stephen Powis, national medical director for the National Health Service in England, said the condition of the two people who received the vaccine are recovering well A nurse prepares …
- General
UK Warns People With Serious Allergies to Avoid Pfizer Covid-19 Vaccine After Two Adverse Reactions
A small shopping basket filled with vials labeled “COVID-19 – Coronavirus Vaccine” and medical sryinges are placed on a Pfizer logo in this illustration. (Reuters) The warning came after two …
-
The Indian Council of Medical Research (ICMR) is conducting an inquiry into a reaction to AstraZeneca’s COVID-19 vaccine trial. A senior official at AstraZeneca told Reuters on Sunday that even …
- News
Coronavirus | ‘Covishield’ vaccine volunteer sues Serum Institute of India, Oxford Group over ‘adverse reaction’
The person’s discharge summary says he was recovering from ‘acute encephalopathy’. A 40-year-old volunteer for ‘Covishield’, the candidate vaccine being tested by the Pune-based Serum Institute of India (SII), has …
-
India’s pharmaceutical company Bharat Biotech International Ltd has now, months later, revealed that during Phase 1 of the human trial of COVID-19 vaccine, the company had an adverse event. In August …